Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-07 Sandrock Alfred Head of Research & Development Sale −7,672 $440.00 $3.4M 10,169.11
2021-02-18 Sandrock Alfred EVP, Research & Development Grant or award · Restricted Stock Unit +14,500 14,500
2021-02-12 Sandrock Alfred EVP, Research & Development Shares withheld for taxes −1,533 $278.03 $426K 15,261.21
2021-02-12 Sandrock Alfred EVP, Research & Development Option exercise +1,300 16,561.21
2021-02-12 Sandrock Alfred EVP, Research & Development Option exercise +1,446 18,007.21
2021-02-12 Sandrock Alfred EVP, Research & Development Option exercise +1,708 19,715.21
2021-02-12 Sandrock Alfred EVP, Research & Development Shares withheld for taxes −577 $278.03 $160K 19,138.21
2021-02-12 Sandrock Alfred EVP, Research & Development Shares withheld for taxes −642 $278.03 $178K 18,496.21
2021-02-12 Sandrock Alfred EVP, Research & Development Shares withheld for taxes −758 $278.03 $211K 17,738.21
2021-02-12 Sandrock Alfred EVP, Research & Development Option exercise · Restricted Stock Unit −1,300 1,466
2021-02-12 Sandrock Alfred EVP, Research & Development Other disposition · Restricted Stock Unit −1,466 0
2021-02-12 Sandrock Alfred EVP, Research & Development Option exercise · Restricted Stock Unit −1,446 5,442
2021-02-12 Sandrock Alfred EVP, Research & Development Other disposition · Restricted Stock Unit −1,996 3,446
2021-02-12 Sandrock Alfred EVP, Research & Development Option exercise · Restricted Stock Unit −1,708 10,352
2021-02-12 Sandrock Alfred EVP, Research & Development Other disposition · Restricted Stock Unit −2,310 8,042
2021-01-27 Sandrock Alfred EVP, Research & Development Grant or award +3,728 16,794.21
2020-11-04 Sandrock Alfred EVP, Research & Development Sale −1,500 $350.00 $525K 13,066.21
2020-02-15 Sandrock Alfred EVP, Research & Development Option exercise +1,213 15,019.25
2020-02-15 Sandrock Alfred EVP, Research & Development Shares withheld for taxes −538 $333.00 $179K 14,481.25
2020-02-15 Sandrock Alfred EVP, Research & Development Option exercise · Restricted Stock Unit −1,213 915

Page 1 of 4 · 77 trades